Who makes Atropine, Fentanyl, Mivacurium?

Atropine, Fentanyl, Mivacurium is developed by University of Ulm.

What development phase is Atropine, Fentanyl, Mivacurium in?

Atropine, Fentanyl, Mivacurium is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Atropine, Fentanyl, Mivacurium

University of Ulm · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Atropine, Fentanyl, Mivacurium
Sponsor	University of Ulm
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Atropine, Fentanyl, Mivacurium CI brief — competitive landscape report
Atropine, Fentanyl, Mivacurium updates RSS · CI watch RSS
University of Ulm portfolio CI